Plain-English translation of NCT06870812 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
The REACH trial is testing a newer, less invasive surgical approach to treat a serious type of stroke caused by bleeding deep inside the brain. Researchers want to see if using minimally invasive surgery to remove the blood clot โ combined with standard medical care โ helps patients recover better and live longer than medication alone.
For many years, doctors have mainly treated this type of brain bleeding with medication. Recent research showed that minimally invasive surgery works well for bleeding closer to the brain's surface, so doctors want to test whether this treatment also helps when the bleeding is deeper inside the brain.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, you will be randomly assigned to either receive minimally invasive surgery (plus standard medical care) or standard medical care alone. If you are assigned to surgery, the procedure would typically happen within 24 hours of your stroke. You will be closely monitored during your hospital stay and will have follow-up visits afterward to measure your recovery and overall health, with your progress tracked according to standard guidelines.
AI-generated summary from trial data ยท Jul 13, 2026 ยท Not medical advice
United States